Insecticides (india) Limited · NSE:INSECTICID
Insecticides (india) — Q4 FY2021 Earnings Presentation
30 slides from Insecticides (india)'s earnings presentation, Jun 19, 2021
Slide 1: Exchange cover letter for earnings presentation
Regd. 8. Corporate Office: 401-402, lusa Tower Azadpur Commercial Complex, Delhi -110 033 Telefax: + 91 11 27679700-05 (6 lines) ISO 9001'2015 14001'2015 & 45001:2018 email: infa@insecticidesindia.com ~IU~I~IU~I~ u~ • www.insecticidesindia.com (IN: L65991 DLl996PLC083909 • • CERTIFIED COMPANY Ref: I
Slide 2: Q4 and Full Year FY2021 Earnings Presentation
(BSE: 532851 NSE: INSECTICID) Q4 and Full Year FY2021 Earnings Presentation
Slide 3: FY2021 - Year in Review
FY2021 - Year in Review Product Premiumization Higher Acceptance Maharatna Products: in the Market Growth Driver New Patent Registration • 7 new Products launched in FY21 • Sale of products launched in FY20 • Maharatna category contributed • Patent received for Synergistic grew by 44% YoY 46% to bra
Slide 4: Q4 FY2021 Highlights
Q4 FY2021 Highlights Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 7.1% 2,556 2,387 287 220 11.2% 8.5% (25) Q4 FY20 Q4 FY21 (73) Q4 FY20 Q4 FY21 Q4 FY20 Q4 FY21 EBITDA Margin (%) PAT Margin (%) Quarter Highlights: • Strong rebound in sales and profitability in Q4 FY2021
Slide 5: FY2021 Highlights
FY2021 Highlights Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 4.2% 2.3% 8.6% 14,202 13,632 1,559 1,523 934 860 11.4% 10.7% 6.3% 6.5% FY20 FY21 FY20 FY21 FY20 FY21 EBITDA Margin (%) PAT Margin (%) Full Year Highlights: • Revenue from operations increased by 4.2% on y-o-
Slide 6: Products Freshness Index
Products Freshness Index Proven track record of successful new product launches exhibits IIL’s strong R&D capabilities and continues to provide competitive edge 571 535 Gross Revenue from new product launches (Rs. Cr.) 30 507 478 70 90 32 420 66 43 89 59 76 131 92 299 148 25 90 11 9 80 13 9 221 33 4
Slide 7: Management Commentary
Management Commentary Commenting on the results, Mr. Rajesh Aggarwal, Managing Director, said: “In Q4 FY2021, IIL delivered a strong rebound in sales and profitability both on sequential and year on year basis. The Company recorded Revenue from Operations of Rs. 256 crores, with a resilient growth o
Slide 8: Growth Strategy
Growth Strategy R& D will results in New product Phase out Generic Products Exports launches in Maharatna Category • Focus on in-house R&D and international • Working on registration in new • Phasing out the Generic Products (high partners to launch new products countries with 100+ export agreements
Slide 9: Business Overview
Business Overview Insecticides India - A Leading Agro Chemicals Manufacturing Company Engaged in the manufacturing and marketing of crop-protection products Rs. 1,420 Cr 60,000+ Four product categories: Insecticides, Herbicides, Fungicides, FY21 Sales Retail Outlets Biologicals and Plant Growth Regu
Slide 10: Capabilities and Geographical Presence
Capabilities and Geographical Presence R&D Manufacturing • NABL QC Labs • 5 Formulations plant • In-house R&D Centre 01 02 • 2 Technical synthesis plants • JV with OAT Agrio Co. • 1 Biological manufacturing plant* Japan for dedicated R&D Centre Development Marketing & Training 04 03 • Sale & market
Slide 11: Research & Development
Research & Development Medium Term: To launch latest technology Short Term: Launch new generic products Long Term: Launch proprietary discovery products through international partners; going off-patent (Reverse Engineering) products (chemicals and biologicals) launch new combination products State-o
Slide 12: Manufacturing Sites
Manufacturing Sites Formulation Unit 1: Chopanki, Rajasthan Formulation Unit 4: Samba, J&K Technical Unit 1: Chopanki, Rajasthan (Technical Production started in 2007) Formulation Unit 2: Chopanki, Rajasthan Formulation Unit 5: Udhampur, J&K Formulation Unit 3: Dahej, Gujarat Technical Unit 2: Dahej
Slide 13: Leading Maharatna Brands
Leading Maharatna Brands LETHAL : Organo-phosphorus group of insecticides; controls insects through contact, stomach and vapour action PULSOR : Systemic fungicide with preventive and curative action; controls Rice Sheath Blight HERCULES Hercules is a broad-spectrum insecticide for control of sucking
Slide 14: Board of Directors and Management
Board of Directors and Management Board of Directors Key Management • Mr. H.C. Aggarwal, Chairman • Mr. Rajesh Aggarwal, Managing Director • Mrs. Nikunj Aggarwal, Whole Time Director • Mr. Virjesh Kumar Gupta, Independent Director H.C. H.C.Aggarwal Aggarwal RajeshAggarwal Rajesh Aggarwal Sandeep Agg
Slide 15: Financial Performance
Financial Performance Q4 Y-o-Y Q3 Q-o-Q Full Year Y-o-Y (Rs. Million) FY2021 FY2020 Growth(%) FY2021 Growth(%) FY2021 FY2020 Growth(%) Operating Revenue 2,556 2,387 7.1% 2,992 (14.6)% 14,202 13,632 4.2% Other Income 21 (9) - 10 106.7% 77 26 201.2% Total Revenue 2,577 2,378 8.4% 3,002 (14.1)% 14,280
Slide 16: Leverage Profile
Leverage Profile Focus on strengthening balance sheet and cash position (Rs. Million) FY2017 FY2018 FY2019 FY2020 FY2021 Long Term Debt 283 145 68 19 23* Company continues to strengthen Balance sheet through debt reduction and Short Term Debt 2,060 968 2,952 1,835 916 improving collection process To
Slide 17: Financial Trends - Annual
Financial Trends - Annual Consistent Revenue and profitability growth in last 5 years Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 9.3% 8.1% 11.8% CAGR CAGR CAGR 13,632 14,202 11,935 1,872 1,224 10,733 1,559 9,942 1,478 1,523 934 840 860 1,114 597 15.7% 13.8% 10.2% 11.2
Slide 18: Key Ratios
Key Ratios Consistently high returns to shareholders and strong capital structure Dividend Payout Ratio Return on Equity 18.5% 15.3% 4.82 12.9% 11.8% 11.4% 2.41 2.41 2.41 2.00 8.3% 11.6% 5.9% 4.1% 4.4% FY17 FY18 FY19 FY20 FY21 FY17 FY18 FY19 FY20 FY21 DPS Payout Ratio Return on Capital Employed Net
Slide 19: Cash Flow from Operations vs Free Cash Flows
Cash Flow from Operations vs Free Cash Flows Generated strong cash flows to support growth plans and mitigate potential risk (Rs. Mn) 2,419 2,134 1,815 1,535 1,554 1,077 40 (99) (1,331) (1,706) FY2017 FY2018 FY2019 FY2020 FY2021 Cash Flow from Operations Free Cash Flows 18
Slide 20: Working Capital Cycle
Working Capital Cycle Management is fully committed to improving its working capital cycle (Working Capital Days) 313 263 226 209 195 188 189 184 158 168 116 124 124 98 89 78 80 75 86 65 Payables Receivables Inventory Net Working Capital FY2017 FY2018 FY2019 FY2020 FY2021 • Net working capital days
Slide 21: Financial Trends - Quarterly
Financial Trends - Quarterly Revenue from Operations (Rs. Mn) EBITDA (Rs. Mn) Profit after Tax (Rs. Mn) 4,558 4,096 577 492 2,992 414 2,387 2,556 287 241 220 151 12.0% 12.7% 11.2% 9.0% 60 8.5% 5.0% 5.9% 2.0% Q4 FY20 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 (25) Q4 FY20 Q1 FY21 Q2 FY21 Q3 FY21 Q4 FY21 (73) Q4
Slide 22: Segment Reporting – FY2021
Segment Reporting – FY2021 Net Sales by Product Category Net Sales by Segment 9% 2% 4% 26% Insecticides 31% B2C 58% Herbicides 70% B2B Fungicides Exports PGR Net Sales vs Internal Consumption Breakdown of Top Seller Range in B2C Sales 50% 50% 46% Maharatna 54% Internal Products Consumption Other Pro
Slide 23: Segment Reporting – FY2021
Segment Reporting – FY2021 Net Sales by Segment (Rs. Mn) Net Sales by Emphasized Product Category (Rs. Mn) -0.4% +19.7% -1.7% +3.7% -3.6% 9,883 9,847 5,510 5,313 4,373 4,534 3,129 3,745 620 610 B2C B2B Exports Maharatna Products Other Products FY20 FY21 FY20 FY21 • Growth in B2B segment while margin
Slide 24: Recent Announcements
Recent Announcements Insecticides (India) received patent for Synergistic Fungicidal Composition Comprising Hexaconazole and Carbendazim • Term of 20 years, from 15th June 2017 • Sold under the Brand Name “SOFIA” • Active Ingredient: Hexaconazole 4% + Carbendazim 16% SC • Product Category: Systemic
Slide 25: 2021 Outlook
2021 Outlook Opportunities India is currently the world’s fourth largest producer of Quarterly Outlook agrochemicals. Normal monsoon and improved kharif Kharif season is expected to be string due to normal performance should drive growth. India’s current monsoon season, timely start of sowing and ex
Slide 26: Disclaimer
Disclaimer This presentation contains statements that contain “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Insecticides (India) Limited (“Insecticides (India)” or the Company) futu
Slide 27: Insecticides (India) Ltd. contact details
Insecticides (India) Ltd. (CIN: L65991DLl996PLC083909) 401-402, Lusa Tower Azadpur Commercial Complex Delhi - 110033 Telefax: +91 11 - 27679700 - 04 (5 Lines) info@insecticidesindia.com www.insecticidesindia.com
Slide 28: Q4 and Full Year FY2021 Results - Press Release
Press Release June 18, 2021 Q4 and Full Year FY2021 Results - Press Release Delhi, India, June 18, 2021: Insecticides (India) Limited (referred to as “IIL” the “Company”), one of the premier agrochemical companies in India, today announced its financial results for the fiscal quarter and full year e
Slide 29: Press Release: Financial Results (continued)
Press Release June 18, 2021 During the year, the key strategic focus areas was on cash sales and better working capital management to generate strong cash flows. As a result, the Company generated cash from operations of Rs. 155 crores and the total debt was further reduced by Rs. 92 crores. In addi
Slide 30: About Insecticides (India)
Press Release June 18, 2021 About Insecticides (India): Insecticides (India) Ltd. (IIL), is a BSE and NSE listed, India's leading and one of the fast growing Agrochemicals manufacturing company. IIL has emerged as a front-line performer in India's crop care market and is all set to grow impressively
Insecticides (India) — Q4 FY2021 Earnings Presentation on 6ix